Evidence map›Paper›PMID 30460339›Full record

ArticleJBMR plus2018

Dynamic Analyses of the Short-Term Effects of Different Bisphosphonates Using Intravital Two-Photon Microscopy.

Junichi Kikuta, Mai Shirazaki, Takao Sudo, Hiroki Mizuno, Akito Morimoto, Riko Suehara, Masafumi Minoshima, Kazuya Kikuchi, Masaru Ishii

Abstract read
In one paragraph

Article in JBMR plus, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. ACS central science · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Junichi KikutaDepartment of Immunology and Cell Biology Graduate School of Medicine and Frontier Biosciences Osaka University 2-2 Yamada-oka Suita Osaka 565-0871 Japan.
Mai ShirazakiDepartment of Immunology and Cell Biology Graduate School of Medicine and Frontier Biosciences Osaka University 2-2 Yamada-oka Suita Osaka 565-0871 Japan.
Takao SudoDepartment of Immunology and Cell Biology Graduate School of Medicine and Frontier Biosciences Osaka University 2-2 Yamada-oka Suita Osaka 565-0871 Japan.
Hiroki MizunoDepartment of Immunology and Cell Biology Graduate School of Medicine and Frontier Biosciences Osaka University 2-2 Yamada-oka Suita Osaka 565-0871 Japan.
Akito MorimotoDepartment of Immunology and Cell Biology Graduate School of Medicine and Frontier Biosciences Osaka University 2-2 Yamada-oka Suita Osaka 565-0871 Japan.
Riko SueharaDepartment of Immunology and Cell Biology Graduate School of Medicine and Frontier Biosciences Osaka University 2-2 Yamada-oka Suita Osaka 565-0871 Japan.
Masafumi MinoshimaDepartment of Material and Life Science Graduate School of Engineering Osaka University 2-1 Yamada-oka Suita Osaka 565-0871 Japan.
Kazuya KikuchiDepartment of Material and Life Science Graduate School of Engineering Osaka University 2-1 Yamada-oka Suita Osaka 565-0871 Japan.
Masaru IshiiDepartment of Immunology and Cell Biology Graduate School of Medicine and Frontier Biosciences Osaka University 2-2 Yamada-oka Suita Osaka 565-0871 Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bisphosphonates are commonly used for the treatment of bone disorders such as osteoporosis; however, the mechanism by which they affect the dynamics of living mature osteoclasts in vivo remains unknown. Here, we describe the short-term effects of different bisphosphonates on controlling the bone resorptive activity of mature osteoclasts in living bone tissues of mice using intravital two-photon microscopy with a pH-sensing chemical fluorescent probe. Three types of nitrogen-containing bisphosphonates, risedronate, alendronate, and minodronate, inhibited osteoclastic acidification during osteoporotic conditions just 12 hours after i.v. injection. Among the three types of drugs, risedronate was the most effective at increasing osteoclast motility and changing the localization of proton pumps, which led to an inhibition of bone resorption. Together, these results demonstrate that the intravital imaging system is a useful tool for evaluating the similarities and differences in currently used antibone resorptive drugs. © 2018 The Authors.

Identifiers

PMID30460339
PMCPMC6237210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.